Translating today's discoveries in childhood cancer research into tomorrow's treatments.

One of only two institutes in the United States dedicated solely to pediatric cancer research, the Greehey Children’s Cancer Research Institute, with its 18 laboratories, focuses its strengths in cancer genomics, DNA repair, RNA biology, and drug development to find new and less toxic treatments for childhood cancers.

Our strengths include cancer genomics, DNA damage, RNA biology, and drug development. We are developing expertise in drug delivery, with a focus on nanotechnology-driven delivery of small RNA mimics and inhibitors.

Learn More


Help us make a difference

Top stories

Raushan Kurmasheva
The Journal of Clinical Medicine Special Issue: The Current Treatment of Childhood Cancer”, for which Dr. Raushan Kurmasheva is Guest Editor
Dr. Ignatius with Zebra fish for his research project
Nature Communications: Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma (Ignatius, Houghton, Chen)
Yogesh Gupta PhD
5-year $3.0 million R01 NIH/NIAID Grant Awarded to Yogesh Gupta, PhD. 
Aune
NIH Grant Awarded to Collaborative Team to Eradicate Ewing Sarcoma (Aune)

Featured Video